Marijuana Use and Type 2 Diabetes Mellitus: a Review

  title={Marijuana Use and Type 2 Diabetes Mellitus: a Review},
  author={Stephen Sidney},
  journal={Current Diabetes Reports},
  • S. Sidney
  • Published 17 October 2016
  • Medicine
  • Current Diabetes Reports
Marijuana is used by millions of people, with use likely to increase in the USA because of the trend towards increased decriminalization and legalization. Obesity and diabetes mellitus (DM) rates have increased dramatically in the USA over the past 30 years, with a recent estimate of 29 million individuals with DM. Because there is a plausible link between marijuana use and diabetes due to the known effects of cannabinoids on adipose tissue and glucose/insulin metabolism, it is important to… 
Diabetes and Cannabis: Myth or Reality
More clinical studies are required to demonstrate that marijuana activates the balance between metabolism and glucose and therefore demonstrate that this "medicinal" plant can help patients who already have the disease to decrease their dependence on insulin.
Diabetes mellitus and illicit drugs.
Patients with DM who use illicit drugs should be sufficiently informed about health risks related to illicit drug use in combination with DM, which might lead to worsened glycemic control and increased morbidity and mortality of the patients.
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
A population-based case-control study of 5,950,391 patients using the 2014 Healthcare Cost and Utilization Project, Nationwide Inpatient Survey (NIS) discharge records of patients 18 years and older suggests that cannabis use is associated with lower prevalence of NAFLD in patients.
Efectos del consumo de marihuana en adultos sobre la ingesta y el metabolismo de los nutrientes: una revisión
It is found that the consumption of marijuana influences increasing the orexigenic stimulus and decreasing the anorexigenic stimuli, which influence increasing the ingestion and changing the production of important enzymes in the metabolism of fat.
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
It is found that former and, to a greater extent, current cannabis use were consistently associated with smaller waist circumference, lower BMI, and lower risks of overweight, obesity, and central obesity in patients with chronic HCV infection.
Cannabis use and risk of type 2 diabetes: a two-sample Mendelian randomization study
The evidence base is added that cannabis use does not play a causal role in type 2 diabetes and genome-wide association study data shows no change in estimates.
Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.
This statement critically reviews the use of medicinal and recreational cannabis from a clinical but also a policy and public health perspective by evaluating its safety and efficacy profile, particularly in relationship to cardiovascular health.
Cannabis use does not impact on type 2 diabetes: A two‐sample Mendelian randomization study
The evidence base is added that cannabis use does not play a causal role in type 2 diabetes and genome‐wide association study data is linked to no substantive change in the estimates.


The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.
Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study
Marijuana use in young adulthood is associated with an increased risk of prediabetes by middle adulthood, but not with the development of diabetes by this age.
Body Mass Index and Marijuana Use
Findings provide support for overeating as competition for drugs and alcohol in brain reward sites during morbid obesity/weight management inbrain reward sites.
Obesity and cannabis use: results from 2 representative national surveys.
The authors conclude that the prevalence of obesity is lower in cannabis users than in nonusers.
Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III
Marijuana use was independently associated with a lower prevalence of diabetes mellitus, and a robust multivariate model controlling for socio-demographic factors, laboratory values and comorbidity found the lower odds of DM among marijuana users was significant.
Triggering Myocardial Infarction by Marijuana
Comparing the reported use of marijuana in the hour preceding symptoms of myocardial infarction onset to its expected frequency may provide insight into the triggering of my Cardiac Infarction by this and other, more common stressors.
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men
Evidence is provided for a relationship in men between a key endocannabinoid, 2-AG, and cardiometabolic risk factors, including IAA, which was shown to reduce complications of type 2 diabetes and cardiovascular disease.
Cannabis Use and Obesity and Young Adults
Multivariate analysis showed that those who had used cannabis were less likely to be categorised in the BMI ≥ 25 group with the least prevalence of overweight/obesity being observed in every day cannabis users.